Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 2
1973 1
1978 4
1979 1
1981 1
1985 1
1988 4
1989 4
1990 4
1991 7
1992 1
1993 3
1994 5
1995 8
1996 5
1997 1
1998 6
1999 6
2000 4
2001 7
2002 2
2003 4
2004 5
2005 3
2006 7
2007 5
2008 5
2009 6
2010 5
2011 3
2012 5
2013 12
2014 9
2015 10
2016 17
2017 14
2018 8
2019 12
2020 17
2021 12
2022 17
2023 6

Text availability

Article attribute

Article type

Publication date

Search Results

239 results

Results by year

Filters applied: . Clear all
Page 1
Hypertrophic Cardiomyopathy: An Overview of Genetics and Management.
Teekakirikul P, Zhu W, Huang HC, Fung E. Teekakirikul P, et al. Biomolecules. 2019 Dec 16;9(12):878. doi: 10.3390/biom9120878. Biomolecules. 2019. PMID: 31888115 Free PMC article. Review.
Hypertrophic cardiomyopathy (HCM) is a genetically heterogeneous cardiac muscle disorder with a diverse natural history, characterized by unexplained left ventricular hypertrophy (LVH), with histopathological hallmarks including myocyte enlargement, myocyte disarray …
Hypertrophic cardiomyopathy (HCM) is a genetically heterogeneous cardiac muscle disorder with a diverse natural history, chara …
ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy.
Gallo S, Vitacolonna A, Bonzano A, Comoglio P, Crepaldi T. Gallo S, et al. Int J Mol Sci. 2019 May 1;20(9):2164. doi: 10.3390/ijms20092164. Int J Mol Sci. 2019. PMID: 31052420 Free PMC article. Review.
Specific ERK-associated scaffold proteins are implicated in either cardioprotective or detrimental hypertrophic functions. Interestingly, ERK phosphorylated at threonine 188 and activated ERK5 (the big MAPK 1) are associated with pathological forms of hypertrophy. Finally, …
Specific ERK-associated scaffold proteins are implicated in either cardioprotective or detrimental hypertrophic functions. Interestin …
Differentiating Athlete's Heart From Cardiomyopathies - The Left Side.
Brosnan MJ, Rakhit D. Brosnan MJ, et al. Heart Lung Circ. 2018 Sep;27(9):1052-1062. doi: 10.1016/j.hlc.2018.04.297. Epub 2018 May 16. Heart Lung Circ. 2018. PMID: 29891249 Review.
This chapter will focus on the left side of the heart, where left ventricular cavity enlargement, increase in left ventricular wall thickness and increased left ventricular trabeculation associated with athletic remodelling may sometimes be difficult to differentiate from conditi …
This chapter will focus on the left side of the heart, where left ventricular cavity enlargement, increase in left ventricular wall thicknes …
Apical Hypertrophic Cardiomyopathy: The Variant Less Known.
Hughes RK, Knott KD, Malcolmson J, Augusto JB, Mohiddin SA, Kellman P, Moon JC, Captur G. Hughes RK, et al. J Am Heart Assoc. 2020 Mar 3;9(5):e015294. doi: 10.1161/JAHA.119.015294. Epub 2020 Feb 28. J Am Heart Assoc. 2020. PMID: 32106746 Free PMC article. Review. No abstract available.
Advances in Clinical Cardiology 2021: A Summary of Key Clinical Trials.
Savage P, Cox B, Linden K, Coburn J, Shahmohammadi M, Menown I. Savage P, et al. Adv Ther. 2022 Jun;39(6):2398-2437. doi: 10.1007/s12325-022-02136-y. Epub 2022 Apr 28. Adv Ther. 2022. PMID: 35482250 Free PMC article. Review.
Heart failure data included trials with sodium-glucose cotransporter 2 (SGLT2) inhibitors, sacubitril/valsartan and novel drugs such as mavacamten for hypertrophic cardiomyopathy (HCM). Prevention trials included new data on proprotein convertase subtilisin/kexin ty …
Heart failure data included trials with sodium-glucose cotransporter 2 (SGLT2) inhibitors, sacubitril/valsartan and novel drugs such as mava …
Causes of sudden cardiac death in young athletes and non-athletes: systematic review and meta-analysis: Sudden cardiac death in the young.
D'Ascenzi F, Valentini F, Pistoresi S, Frascaro F, Piu P, Cavigli L, Valente S, Focardi M, Cameli M, Bonifazi M, Metra M, Mondillo S. D'Ascenzi F, et al. Trends Cardiovasc Med. 2022 Jul;32(5):299-308. doi: 10.1016/j.tcm.2021.06.001. Epub 2021 Jun 22. Trends Cardiovasc Med. 2022. PMID: 34166791 Review.
Comparing the causes of SCD between athletes and non-athletes, non-ischemic left ventricular scar (NILVS) (5.1% vs. 1.1%, p=0.01) was more frequent in the former, while coronary artery disease (CAD) (19.6% vs. 9.1%, p=0.009), arrhythmogenic cardiomyopathy (ACM) (11. …
Comparing the causes of SCD between athletes and non-athletes, non-ischemic left ventricular scar (NILVS) (5.1% vs. 1.1%, p=0.01) was more f …
Incidence and Etiology of Sudden Cardiac Death: New Updates for Athletic Departments.
Asif IM, Harmon KG. Asif IM, et al. Sports Health. 2017 May/Jun;9(3):268-279. doi: 10.1177/1941738117694153. Epub 2017 Feb 1. Sports Health. 2017. PMID: 28452637 Free PMC article. Review.
Initial reports suggest that the most common cause of SCD is hypertrophic cardiomyopathy (HCM). However, more comprehensive investigations in the United States and international populations-athletes, nonathletes, and military-support that the most common finding on …
Initial reports suggest that the most common cause of SCD is hypertrophic cardiomyopathy (HCM). However, more comprehensive in …
The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms.
Andrade J, Khairy P, Dobrev D, Nattel S. Andrade J, et al. Circ Res. 2014 Apr 25;114(9):1453-68. doi: 10.1161/CIRCRESAHA.114.303211. Circ Res. 2014. PMID: 24763464 Review.
Emerging risk factors include prehypertension, increased pulse pressure, obstructive sleep apnea, high-level physical training, diastolic dysfunction, predisposing gene variants, hypertrophic cardiomyopathy, and congenital heart disease. Potential risk factors are c …
Emerging risk factors include prehypertension, increased pulse pressure, obstructive sleep apnea, high-level physical training, diastolic dy …
Prognostic Value of LGE-CMR in HCM: A Meta-Analysis.
Weng Z, Yao J, Chan RH, He J, Yang X, Zhou Y, He Y. Weng Z, et al. JACC Cardiovasc Imaging. 2016 Dec;9(12):1392-1402. doi: 10.1016/j.jcmg.2016.02.031. Epub 2016 Jul 20. JACC Cardiovasc Imaging. 2016. PMID: 27450876 Free article. Review.
OBJECTIVES: The aims of this study included performing a meta-analysis of the predictive value of late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) for adverse events and death in hypertrophic cardiomyopathy (HCM). BACKGROUND: CMR with LGE can ident …
OBJECTIVES: The aims of this study included performing a meta-analysis of the predictive value of late gadolinium enhancement (LGE) cardiac …
Dilated cardiomyopathy: the complexity of a diverse genetic architecture.
Hershberger RE, Hedges DJ, Morales A. Hershberger RE, et al. Nat Rev Cardiol. 2013 Sep;10(9):531-47. doi: 10.1038/nrcardio.2013.105. Epub 2013 Jul 30. Nat Rev Cardiol. 2013. PMID: 23900355 Review.
Remarkable progress has been made in understanding the genetic basis of dilated cardiomyopathy (DCM). Rare variants in >30 genes, some also involved in other cardiomyopathies, muscular dystrophy, or syndromic disease, perturb a diverse set of important myocardial protei …
Remarkable progress has been made in understanding the genetic basis of dilated cardiomyopathy (DCM). Rare variants in >30 genes, …
239 results